Alan K Smith - EVP, Bellicum Pharmaceuticals, Inc

As of April 9, 2020

Net worth is estimated to be at least $21.37K
Owns at least 2,087 units of Bellicum Pharmaceuticals, Inc stock
Sold an estimated value of $17.68K in the last 3 years at Bellicum Pharmaceuticals, Inc

Largest sale of shares was 437 units , worth over $5.18K on July 26, 2017
In total has made about 9 transactions over 3 years
Usually trades in January, with the busiest year in 2020, 2017 and 2018

	Ticker	Type	Value	Price per Share	Shares	Filing Date
No matching records found

Mailing address is C/o Bellicum Pharmaceuticals, Inc. 2130 W. Holcombe Blvd., Ste. 800 Houston TX 77030 TX

Name	Year	Salary	Stock Awards	Option Awards	Other Earnings Plans or Compensations	Other Compensation	Total
Richard A. Fair,	2020	$625,910	-	$1,786,412	$249,190	$21,433	$2,682,945
Richard A. Fair,	2019	$566,204	-	$1,021,004	$127,990	$17,690	$1,732,888
Atabak Mokari,	2020	$408,373	$163,764	$542,889	-	$536,708	$1,651,734
Atabak Mokari,	2019	$375,000	-	$669,168	$61,500	$2,233	$1,107,901
Shane M. Ward,	2020	$407,752	$164,114	$412,193	-	$552,275	$1,536,334
Shane M. Ward,	2019	$374,062	-	$153,151	$61,705	$17,941	$606,859
No matching records found

The most recent transaction was 5,000 units bought on March 19, 2020 by Richard A Fair worth over $20K
In the last 5 years, insiders at Bellicum Pharmaceuticals, Inc sold an estimated value of $18.67M and bought an estimated value of $2.85M
The most active traders are David Spencer, Chief Technology Officer, Kevin Slawin, Director, and Alan A Musso, CFO and Treasurer
Insider trading is most common in June, with the busiest year in 2016

	Insider Names	Type	Value	Price per Share	Shares	Filing Date
No matching records found